Q32 Bio Inc.
QTTB
$3.66
$0.257.33%
NASDAQ
| 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | |
|---|---|---|---|---|---|
| Net Income | 30.54% | 8.31% | -30.34% | 11.18% | -66.68% |
| Total Depreciation and Amortization | -14.26% | -7.93% | -2.42% | -2.40% | -2.39% |
| Total Amortization of Deferred Charges | 9.71% | 48.48% | 134.07% | 122.99% | 113.41% |
| Total Other Non-Cash Items | 151.64% | 202.67% | 163.47% | -235.04% | -231.77% |
| Change in Net Operating Assets | -177.13% | -126.04% | -135.25% | -136.62% | -87.22% |
| Cash from Operations | 42.10% | -71.26% | -216.64% | -262.56% | -4,400.51% |
| Capital Expenditure | 97.26% | -275.00% | -- | -1,400.00% | -1,360.00% |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -100.00% | 0.00% | 20,418.56% | -- | -- |
| Cash from Investing | -100.01% | -0.44% | 20,341.24% | 398,600.00% | 142,235.71% |
| Total Debt Issued | -188.36% | -180.96% | -100.00% | 27.27% | 171.39% |
| Total Debt Repaid | 182.06% | 162.63% | 100.00% | 100.00% | -67.58% |
| Issuance of Common Stock | -99.27% | -96.91% | -95.98% | 41,120.75% | 144,743.33% |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -111.72% | -- | -- |
| Cash from Financing | -101.31% | -98.61% | -104.22% | 23,333.00% | 458.32% |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -183.73% | -158.99% | -163.24% | 359.07% | 157.54% |